ArticleProceedings of the National Academy of Sciences of the United States of America2019

MiR223-3p promotes synthetic lethality in BRCA1-deficient cancers.

Gayathri Srinivasan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.